Radius Health (RDUS) Tops Q3 EPS by 36c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Radius Health, Inc.: Third Quarter 2020 Operating Results
November 5, 2020 8:00 AM ESTTYMLOS® U.S. net sales of $50 million with 8% year-over-year growth; Total Revenues of $78 millionQ3 commercial pivot to focus on high risk fracture segment is gaining traction: Net New U.S. Patients increased by 7+% in September 2020 vs. previous 3-month moving average and 10 +% in October vs. previous 3 month moving averageJapan market progress on track with our partner Teijin for expected 2021 abaloparatide injection launchThree Pivotal Trial Readouts on track for 2H 2021Conference call scheduled for 8:30 a.m. ET... More
